Liver Disease Patients: Weight Deceives, Muscle Matters Most

In liver disease, body weight is a misleading indicator of health due to concurrent muscle loss and fat gain. Sarcopenia, the progressive decline of skeletal muscle mass and strength, profoundly impacts patient outcomes and survival rates. This condition, affecting both the elderly and those with liver ailments like cirrhosis, necessitates a shift in focus from body weight to actual muscle mass for effective health assessments.

The liver's role as a metabolic hub means that during fasting, muscle protein is utilized for energy, leading to continuous muscle depletion. Furthermore, a compromised liver fails to produce essential proteins, while hormonal shifts and inflammation accelerate muscle tissue destruction. This metabolic disruption causes muscle loss even with adequate food intake.

Sarcopenia can be masked by excess body fat, a condition known as sarcopenic obesity, often seen in non-alcoholic fatty liver disease. This creates a false impression of good health, as standard body mass index calculations do not differentiate between fat and muscle. Muscle plays a vital role in detoxifying ammonia, a byproduct of liver dysfunction. Reduced muscle mass can increase the risk of hepatic encephalopathy and impair recovery from illness or treatments.

Weight assessment is further complicated by fluid accumulation, such as ascites, which artificially influmes body weight and masks underlying muscle wasting. Accurate muscle assessment requires advanced methods like imaging and strength measurements. Fortunately, sarcopenia is manageable and reversible through sufficient protein intake, resistance exercise, and addressing nutritional deficiencies and inflammation.